Komori
Occurring Fact7776CellSeed Inc.Electrical Equipment and Precision Instruments

Notice Regarding the Recording of Non-Operating Income and Expenses and Extraordinary Loss

During the first quarter of the fiscal year ending December 2026, the Company recognized ¥1.491 million in interest income and ¥1.2 million in support payment income as non-operating income, and ¥3.522 million in stock issuance costs as non-operating expenses. In addition, the Company recognized an impairment loss of ¥20.321 million on its tangible fixed assets as an extraordinary loss.

Worth reading
34Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
20321
¥ thousand
Wording
Definitive
How definitive the wording is.

Notice Regarding the Recording of Non-Operating Income and Expenses and Extraordinary Loss

Subject Entity

CellSeed Inc. (the filing company)

Target Locations / Products

Tangible fixed assets held by the Company

This disclosure05/13/2026
Cause

The Company received interest on bank deposits and various subsidies and other support payments, exercised the 25th Series of Stock Acquisition Rights, and identified indications of impairment in its tangible fixed assets, prompting an assessment of their recoverable amounts based on future cash flows.

Amount of Impact on Business Performance

Interest income of ¥1.491 million (non-operating income), support payment income of ¥1.2 million (non-operating income), stock issuance costs of ¥3.522 million (non-operating expenses), and an impairment loss of ¥20.321 million (extraordinary loss)

Accounting period in which recognized

Cumulative first-quarter period of the fiscal year ending December 2026 (1 January 2026 to 31 March 2026)

Impact on Earnings Forecast

Reflected in the Summary of Financial Results for the First Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (non-consolidated), announced today

Event that occurred
ItemDetails
Event nameNotice Regarding the Recording of Non-Operating Income and Expenses and Extraordinary Loss
Subject EntityCellSeed Inc. (the filing company)
Target Locations / ProductsTangible fixed assets held by the Company
CauseThe Company received interest on bank deposits and various subsidies and other support payments, exercised the 25th Series of Stock Acquisition Rights, and identified indications of impairment in its tangible fixed assets, prompting an assessment of their recoverable amounts based on future cash flows.
Amount of Impact on Business PerformanceInterest income of ¥1.491 million (non-operating income), support payment income of ¥1.2 million (non-operating income), stock issuance costs of ¥3.522 million (non-operating expenses), and an impairment loss of ¥20.321 million (extraordinary loss)
Accounting period in which recognizedCumulative first-quarter period of the fiscal year ending December 2026 (1 January 2026 to 31 March 2026)
Impact on Earnings ForecastReflected in the Summary of Financial Results for the First Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (non-consolidated), announced today
Items this document does not state (18)
Date of occurrenceDate recognized / date notice receivedType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changeOutlookPlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company received interest on bank deposits and various subsidies and other support payments, exercised the 25th Series of Stock Acquisition Rights, and identified indications of impairment in its tangible fixed assets, prompting an assessment of their recoverable amounts based on future cash flows.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Recording of Non-Operating Income and Expenses and Extraordinary Loss | CellSeed Inc. (7776) timely disclosure | Komori